{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T17:26:39Z","timestamp":1649093199118},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2004,9,23]],"date-time":"2004-09-23T00:00:00Z","timestamp":1095897600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2004,10]]},"DOI":"10.1007\/s00210-004-0977-7","type":"journal-article","created":{"date-parts":[[2004,9,22]],"date-time":"2004-09-22T15:22:41Z","timestamp":1095866561000},"page":"262-269","source":"Crossref","is-referenced-by-count":5,"title":["A pharmacological differentiation between postjunctional (AT1A) and prejunctional (AT1B) angiotensin II receptors in the rabbit aorta"],"prefix":"10.1007","volume":"370","author":[{"given":"Serafim","family":"Guimar\ufffdes","sequence":"first","affiliation":[]},{"given":"Catarina","family":"Carneiro","sequence":"additional","affiliation":[]},{"given":"Fernando","family":"Brand\ufffdo","sequence":"additional","affiliation":[]},{"given":"Helder","family":"Pinheiro","sequence":"additional","affiliation":[]},{"given":"Ant\ufffdnio","family":"Albino-Teixeira","sequence":"additional","affiliation":[]},{"given":"Daniel","family":"Moura","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2004,9,23]]},"reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1152\/ajplegacy.1948.153.3.586","volume":"153","author":"RP Ahlquist","year":"1948","unstructured":"Ahlquist RP (1948) A study of the adrenotropic receptors. Am J Physiol 153:586?600","journal-title":"Am J Physiol"},{"issue":"Suppl 6","key":"CR2","first-page":"S196","volume":"9","author":"A Albino-Teixeira","year":"1991","unstructured":"Albino-Teixeira A, Matias A, Pol\u00f3nia J, Azevedo I (1991) Blockade of adenosine receptors causes hypertension and cardiovascular structural changes in the rat. J Hypertens 9 [Suppl 6]:S196?S197","journal-title":"J Hypertens"},{"key":"CR3","first-page":"48","volume":"14","author":"O Arunlakshana","year":"1959","unstructured":"Arunlakshana O, Schild HO (1959) Some quantitative uses of drug antagonists. Br J Pharmacol 14:48?58","journal-title":"Br J Pharmacol"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1097\/00004872-200112000-00018","volume":"19","author":"JC Balt","year":"2001","unstructured":"Balt JC, Mathy MJ, Pfaffendorf M, Van Zwieten PA (2001a) Inhibition of facilitation of sympathetic neurotransmission and angiotensin II-induced pressor effects in the pithed rat: comparison between valsartan, candesartan, eprosartan and embusartan. J Hypertens 19:2241?2250","journal-title":"J Hypertens"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/00005344-200107000-00015","volume":"38","author":"JC Balt","year":"2001","unstructured":"Balt JC, Mathy MJ, Nap A, Pfaffendorf M, Van Zwieten PA (2001b) Effect of the AT1-receptor antagonists losartan, irbesartan, and telmisartan on angiotensin II-induced facilitation of sympathetic neurotransmission in the rat mesenteric artery. J Cardiovasc Pharmacol 38:141?148","journal-title":"J Cardiovasc Pharmacol"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/00005344-200207000-00007","volume":"40","author":"JC Balt","year":"2002","unstructured":"Balt JC, Mathy MJ, Nap A, Pfaffendorf M, Van Zwieten PA (2002) Prejunctional and postjunctional inhibitory actions of eprosartan and candesartan in the isolated rabbit mesenteric artery. J Cardiovasc Pharmacol 40:50?57","journal-title":"J Cardiovasc Pharmacol"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1254\/jphs.92.381","volume":"92","author":"S Chiba","year":"2003","unstructured":"Chiba S, Yang X-P (2003) The preferential inhibitory effect of olmesartan, a new angiotensin II type 1 antagonist, on sympathetic nerve terminals in isolated canine splenic artery. J Pharmacol Sci 92:381?386","journal-title":"J Pharmacol Sci"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/j.1476-5381.1995.tb13313.x","volume":"114","author":"SL Cox","year":"1995","unstructured":"Cox SL, Ben A, Story DF, Ziogas J (1995) Evidence for the involvement of different receptor subtypes in pre- and postjunctional actions of angiotensin II at rat sympathetic neuroeffector sites. Br J Pharmacol 114:1057?1063","journal-title":"Br J Pharmacol"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/sj.bjp.0702652","volume":"127","author":"SL Cox","year":"1999","unstructured":"Cox SL, Trendelenburg AU, Starke K (1999) Prejunctional angiotensin receptors involved in the facilitation of noradrenaline release in mouse tissues. Br J Pharmacol 127:1256?1262","journal-title":"Br J Pharmacol"},{"key":"CR10","first-page":"415","volume":"52","author":"M Gasparo De","year":"2000","unstructured":"De Gasparo M, Catt KJ, Inagami T, Wright JW, Unger TH (2000) International union of pharmacology. XXIII. The angiotensin receptors. Pharmacol Rev 52:415?472","journal-title":"Pharmacol Rev"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1097\/00004872-200206000-00027","volume":"20","author":"A Dendorfer","year":"2002","unstructured":"Dendorfer A, Raasch W, Tempel K, Dominiak P (2002) Comparison of the vascular and antiadrenergic activities of four angiotensin II type 1 antagonists in the pithed rat. J Hypertens 20:1151?1156","journal-title":"J Hypertens"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"F776","DOI":"10.1152\/ajpcell.1994.267.3.C776","volume":"267","author":"NO Dulin","year":"1994","unstructured":"Dulin NO, Ernsberger P, Suciu DJ, Douglas JG (1994) Rabbit renal epithelial angiotensin II receptors. Am J Physiol 267:F776?F782","journal-title":"Am J Physiol"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/00005344-200402000-00024","volume":"43","author":"M Muayed El","year":"2004","unstructured":"El Muayed M, Stegbauer J, Oberhauser V, Vonend O, Rump LC (2004) AT1 and AT2-receptor antagonists inhibit Ang II-mediated facilitation of noradrenaline release in human atria. J Cardiovasc Pharmacol 43:318?324","journal-title":"J Cardiovasc Pharmacol"},{"key":"CR14","first-page":"F411","volume":"263","author":"P Ernsberger","year":"1992","unstructured":"Ernsberger P, Zhou J, Damon TH, Douglas JG (1992) Angiotensin II receptor subtypes in cultured rat renal mesangial cells. Am J Physiol 263:F411?F416","journal-title":"Am J Physiol"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1677\/joe.0.1710097","volume":"171","author":"ME Fabiani","year":"2001","unstructured":"Fabiani ME, Sourial M, Thomas WG, Johnston CI, Frauman AG (2001) Angiotensin II enhances noradrenaline release from sympathetic nerves of the rat prostate via a novel angiotensin receptor: implications for the pathophysiology of benign prostatic hyperplasia. J Endocrinol 171:97?108","journal-title":"J Endocrinol"},{"key":"CR16","first-page":"319","volume":"53","author":"S Guimar\u00e3es","year":"2001","unstructured":"Guimar\u00e3es S, Moura D (2001) Vascular adrenoceptors: an update. Pharmacol Rev 53:319?356","journal-title":"Pharmacol Rev"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0014-2999(69)90021-1","volume":"5","author":"S Guimar\u00e3es","year":"1969","unstructured":"Guimar\u00e3es S, Osswald W (1969) Adrenergic receptors in the veins of the dogs. Eur J Pharmacol 5:133?140","journal-title":"Eur J Pharmacol"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/BF00508291","volume":"305","author":"S Guimar\u00e3es","year":"1978","unstructured":"Guimar\u00e3es S, Brand\u00e3o F, Paiva MQ (1978) A study of the adrenoceptor-mediated feedback mechanisms by using adrenaline as a false transmitter. Naunyn-Schmiedebergs Arch Pharmacol 305:185?188","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/sj.bjp.0701959","volume":"124","author":"S Guimar\u00e3es","year":"1998","unstructured":"Guimar\u00e3es S, Paiva MQ, Moura D (1998) Different receptors for angiotensin II at pre- and postjunctional level of the canine mesenteric and pulmonary arteries. Br J Pharmacol 124:1207?1212","journal-title":"Br J Pharmacol"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s002100100396","volume":"363","author":"S Guimar\u00e3es","year":"2001","unstructured":"Guimar\u00e3es S, Pinheiro H, Tavares P, Loio A, Moura D (2001) Differential effects of eprosartan and losartan at prejunctional angiotensin II receptors. Naunyn-Schmiedebergs Arch Pharmacol 363:509?514","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1034\/j.1600-0773.2003.920404.x","volume":"92","author":"S Guimar\u00e3es","year":"2003","unstructured":"Guimar\u00e3es S, Morato M, Sousa T, Albino-Teixeira A (2003) Hypertension due to blockade of adenosine receptors. Pharmacol Toxicol 92:160?162","journal-title":"Pharmacol Toxicol"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1152\/ajplegacy.1964.207.2.368","volume":"207","author":"UM Helmer","year":"1964","unstructured":"Helmer UM (1964) Action of natural angiotensin II and synthetic analogues on strips of rabbit aorta. Am J Physiol 207:368?370","journal-title":"Am J Physiol"},{"key":"CR23","first-page":"145","volume-title":"Pharmacologic analysis of drug-receptor interaction","author":"T Kenakin","year":"1997","unstructured":"Kenakin T (1997) Diffusion and drug concentration in receptor compartments. In: Kenakin K (ed) Pharmacologic analysis of drug-receptor interaction. Lippincott-Raven, Philadelphia, pp 145?197"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/214597a0","volume":"214","author":"AM Lands","year":"1967","unstructured":"Lands AM, Arnold A, McAuliff JP, Luduena FP, Brown TG Jr (1967) Differentiation of receptor systems activated by sympathomimetic amines. Nature 214:597?598","journal-title":"Nature"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/00004872-200103001-00014","volume":"19","author":"X Ma","year":"2001","unstructured":"Ma X, Abboud FM, Chapleau MW (2001) A novel effect of angiotensin on renal sympathetic nerve activity in mice. J Hypertens 19:609?618","journal-title":"J Hypertens"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00210-003-0840-2","volume":"368","author":"A Mota","year":"2003","unstructured":"Mota A, Guimar\u00e3es S (2003) Influence of ?2-autoreceptor stimulation on the facilitation by angiotensin II and bradykinin of noradrenaline release. Naunyn-Schmiedebergs Arch Pharmacol 368:443?447","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/00005344-200401000-00003","volume":"43","author":"A Nap","year":"2004","unstructured":"Nap A, Balt JC, Mathy M-J, Pfaffendorf M, Van Zwieten PA (2004) Different AT1 receptor subtypes at pre- and postjunctional sites: AT1A versus AT1B receptors. J Cardiovasc Pharmacol 43:14?20","journal-title":"J Cardiovasc Pharmacol"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1159\/000139534","volume":"55","author":"EH Ohlstein","year":"1997","unstructured":"Ohlstein EH, Brooks DP, Feuerstein GZ, Ruffolo RR (1997) Inhibition of sympathetic outflow by the angiotensin II receptor antagonist, eprosartan, but not losartan, valsartan or irbesartan: relationship to differences in prejunctional angiotensin II receptor blockade. Pharmacology 55:244?254","journal-title":"Pharmacology"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00210-002-0645-8","volume":"366","author":"H Pinheiro","year":"2002","unstructured":"Pinheiro H, Moura D, Albino-Teixeira A, Alves C, Torres L, Guimar\u00e3es S (2002) A comparison of AT1 angiotensin II antagonists at pre- and postjunctional angiotensin II receptors of the rat tail artery. Naunyn-Schmiedebergs Arch Pharmacol 366:537?542","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"CR30","first-page":"179","volume":"294","author":"SS Shetty","year":"2000","unstructured":"Shetty SS, Delgrande D (2000) Differential inhibition of the prejunctional actions of angiotensin II in rat atria by valsartan, irbesartan, eprosartan and losartan. J Pharmacol Exp Ther 294:179?186","journal-title":"J Pharmacol Exp Ther"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BFb0050157","volume":"77","author":"K Starke","year":"1977","unstructured":"Starke K (1977) Regulation of noradrenaline release by presynaptic receptor systems. Rev Physiol Biochem Pharmacol 77:1?124","journal-title":"Rev Physiol Biochem Pharmacol"},{"key":"CR32","first-page":"956","volume":"263","author":"Y Susuki","year":"1992","unstructured":"Susuki Y, Matsumura Y, Egi Y, Morimoto S (1992) Effects of losartan, a nonpeptide angiotensin II receptor antagonist, on norepinephrine overflow and antidiuresis by stimulation of renal nerves in anaesthetized dogs. J Pharmacol Exp Ther 263:956?963","journal-title":"J Pharmacol Exp Ther"},{"key":"CR33","first-page":"629","volume":"18","author":"U Trendelenburg","year":"1966","unstructured":"Trendelenburg U (1966) Mechanisms of supersensitivity and subsensitivity to sympathomimetic amines. Pharmacol Rev 18:629?640","journal-title":"Pharmacol Rev"},{"key":"CR34","first-page":"211","volume":"255","author":"PC Wong","year":"1990","unstructured":"Wong PC, Price WA Jr, Chiu AT, Duncia JW, Carini DJ, Wexler RR, Johnson AJ, Timmermans PBMWM (1990) Nonpeptide angiotensin II receptor antagonists. XI. Pharmacology of EXP3714: an active metabolite of DuP 753, an orally active antihypertensive agent. J Pharmacol Exp Ther 255:211?217","journal-title":"J Pharmacol Exp Ther"},{"key":"CR35","first-page":"E414","volume":"272","author":"RH Worck","year":"1997","unstructured":"Worck RH, Ibsen H, Frandsen E, Dige-Petersen H (1997) AT1 receptor blockade and sympathoadrenal response to insulin-induced hypoglycemia in humans. Am J Physiol 272:E414?E421","journal-title":"Am J Physiol"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1161\/01.HYP.21.6.1035","volume":"21","author":"J Zhou","year":"1993","unstructured":"Zhou J, Ernsberger P, Douglas JG (1993) A novel angiotensin receptor subtype in rat mesangium coupling to adenylyl cyclase. Hypertension 21:1035?1038","journal-title":"Hypertension"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-004-0977-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00210-004-0977-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-004-0977-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T05:37:43Z","timestamp":1585892263000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00210-004-0977-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9,23]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["977"],"URL":"https:\/\/doi.org\/10.1007\/s00210-004-0977-7","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,9,23]]}}}